Submitted references DNAJB6 isoform specific knockdown: Therapeutic potential for limb girdle muscular dystrophy D1.
Findlay AR, Paing MM, Daw JA, Haller M, Bengoechea R, Pittman SK, Li S, Wang F, Miller TM, True HL, Chou TF, Weihl CC
Molecular therapy. Nucleic acids 2023 Jun 13;32:937-948
Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure.
Weihl CC, Töpf A, Bengoechea R, Duff J, Charlton R, Garcia SK, Domínguez-González C, Alsaman A, Hernández-Laín A, Franco LV, Sanchez MEP, Beecroft SJ, Goullee H, Daw J, Bhadra A, True H, Inoue M, Findlay AR, Laing N, Olivé M, Ravenscroft G, Straub V
Acta neuropathologica 2023 Jan;145(1):127-143
Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
Tang L, An P, Zhao Q, Winkler CA, Chang J, Guo JT
Journal of virology 2023 Jan 31;97(1):e0126122
Distinctive chaperonopathy in skeletal muscle associated with the dominant variant in DNAJB4.
Inoue M, Noguchi S, Inoue YU, Iida A, Ogawa M, Bengoechea R, Pittman SK, Hayashi S, Watanabe K, Hosoi Y, Sano T, Takao M, Oya Y, Takahashi Y, Miyajima H, Weihl CC, Inoue T, Nishino I
Acta neuropathologica 2023 Feb;145(2):235-255
DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway.
Chen Y, Li J, Pu L, Hu J, Fang L, Zhou F, Zhang H, Yang Y, Rong X, Deng S, Hou L
Discover oncology 2023 Aug 7;14(1):144
Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice.
Hsu MC, Luo WJ, Guo BC, Chen CH, Hu PA, Tsai YH, Su KY, Lee TS
International journal of molecular sciences 2022 Feb 13;23(4)
HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages.
Luo WJ, Yu SL, Chang CC, Chien MH, Chang YL, Liao KM, Lin PC, Chung KP, Chuang YH, Chen JJW, Yang PC, Su KY
eLife 2022 Aug 19;11
HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
Acun T, Doberstein N, Habermann JK, Gemoll T, Thorns C, Oztas E, Ried T
Omics : a journal of integrative biology 2017 May;21(5):257-265
HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.
Liu Y, Zhou J, Zhang C, Fu W, Xiao X, Ruan S, Zhang Y, Luo X, Tang M
International journal of clinical and experimental pathology 2014;7(3):969-77
Explore
Validate
Learn
Western blot
ELISA
